10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Aspergillosis can show in a few shapes, each with its claim clinical characteristics and suggestions. Unfavorably susceptible bronchopulmonary aspergillosis (ABPA) could be a response to Aspergillus antigens, basically influencing people with asthma or cystic fibrosis. Constant aspiratory aspergillosis (CPA) may be a and possibly life-threatening lung disease that commonly happens in people with pre-existing lung conditions or compromised resistant frameworks. Obtrusive aspergillosis (IA) is the foremost extreme shape of the disease, ordinarily influencing seriously immunocompromised people, such as those experiencing chemotherapy or organ transplantation. IA can spread past the lungs and influence other organs, driving to systemic complications and tall mortality rates in the event that not instantly treated with antifungal treatment. Early conclusion and suitable administration are significant for making strides results in patients with all shapes of aspergillosis.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria